Structural Heart Devices Market Scope
The structural heart devices market is expected to grow in the future due to a rise in mitral regurgitation, aortic stenosis, and other related heart diseases. Structural heart disease refers to patients suffering from both congenital heart disease and acquired heart disease involving structural and functional abnormalities of heart valves, proximal great vessels, and cardiac chambers. Increasing R&D activities by key players on structural heart devices and an upsurge in demand for quick and long-lasting procedures among the geriatric population are fueling the growth of the structural heart devices market in the forecasted period.
The Structural Heart Devices market study is segmented by Type (Herat Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems, Annuloplasty Rings, Other Devices and Accessories) and major geographies with country level break-up.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Structural Heart Devices market throughout the predicted period.
Edwards Lifesciences Corporation (United States), Medtronic plc (Ireland), Abbott (United States), Boston Scientific Corporation (United States), LivaNova plc (United Kingdom), CryoLife, Inc. (United States), Micro Interventional Devices, Inc. (United States), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China) and TTK Healthcare Limited (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Biomerics (United States) and Lifetech Scientific (China).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Structural Heart Devices market by Type, Application and Region.
On the basis of geography, the market of Structural Heart Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In may 2020, Sahajanand Medical Technologies (SMT) announced its entry into the structural heart segment with an acquisition of medical device firm Vascular Concepts. The acquisition got completed on May 27. Even after the acquisition, Vascular Concept will retain its distinct brand and independence. Swaminathan Jayaraman, CEO, Vascular Concepts will continue to manage the operation of the company.
In Dec 2020, LivaNova PLC and Gyrus Capital (Gyrus) announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business. Gyrus intends to focus management attention and investment on the HV business to position it to become a leading player in the surgical heart valve market globally, translating into even greater opportunities for employees, customers, and patients.
- Technological Advancements in Structural Heart Devices
- Increasing R&D Activities by Key Players on Structural Heart Devices
- Rising Incidence of Structural Heart Diseases
- Increasing Demand for Minimally Invasive Techniques
- Surging Development of Innovative Repair Sevices such as Annuloplasty Rings, Occluders, Etc
- Growth in the Healthcare Industry Worldwide
- High Cost of Surgeries
- Inaccessibility of Cardiac Surgeries in Emerging Economies
- Stringent Government Regulations
- Lack of Skilled Personnel
Key Target AudienceNew Entrants/Investors, Healthcare Industry Associations, Venture Capitalists and Private Equity Firms, Valvular Heart Diseases Treatment Provider, Raw Material Suppliers, End-Use Industries and Analysts and Strategic Business Planners
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase